Terms: = Kidney tumors AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Prognosis
2441 results:
1. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and pathological characteristics of renal cell carcinomas with MiTF translocation.
Filler T; Verkarre V; Peyrottes A; Poinard F; Lupo A; Dariane C; Hurel S; Timsit MO; Mejean A; Audenet F
Fr J Urol; 2024 Mar; 34(2):102569. PubMed ID: 38717457
[TBL] [Abstract] [Full Text] [Related]
3. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
[TBL] [Abstract] [Full Text] [Related]
4. A retrospective clinical analysis of 11 cases of PEComa from different sites.
Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
[TBL] [Abstract] [Full Text] [Related]
5. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study.
Ni J; Yao X; Song W; Zhang H; Zhang H; Wang Y; Zhang Y; Wang G; Wang K; Mao W; Peng B
Cancer Med; 2024 May; 13(9):e7214. PubMed ID: 38686610
[TBL] [Abstract] [Full Text] [Related]
7. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
[TBL] [Abstract] [Full Text] [Related]
8. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
9. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathologic and Molecular Characterization of Xanthomatous Giant Cell Renal Cell Carcinomas: Further Support for a Close Morphologic Spectrum to Eosinophilic Solid and Cystic Renal Cell Carcinomas.
Xu Y; Zhang X; Xia Q; Zhou Y; Wang X; Fang R; Wang Y; Tong Q; Chen J; Shi J; Fu Y; Rao Q
Am J Surg Pathol; 2024 Jun; 48(6):662-670. PubMed ID: 38595297
[TBL] [Abstract] [Full Text] [Related]
11. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma.
Hu Y; Gu Y; Song Y; Zhao Y; Wang J; Ma J; Sui F
Mol Cell Probes; 2024 Jun; 75():101959. PubMed ID: 38579915
[TBL] [Abstract] [Full Text] [Related]
12. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
Xu J; Bai J; Pan H; Zhou Z
Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
[TBL] [Abstract] [Full Text] [Related]
13. ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment.
Pan W; Liu X; Liu S
Medicine (Baltimore); 2024 Apr; 103(14):e37590. PubMed ID: 38579085
[TBL] [Abstract] [Full Text] [Related]
14. Radiogenomic analysis based on lipid metabolism-related subset for non-invasive prediction for prognosis of renal clear cell carcinoma.
He H; Xie Y; Song F; Feng Z; Rong P
Eur J Radiol; 2024 Jun; 175():111433. PubMed ID: 38554673
[TBL] [Abstract] [Full Text] [Related]
15. Heterotopic bone formation in a case of clear cell renal cell carcinoma: A case report.
Bavikar R; Patel P; Verma A; Ingale Y; Randive R
J Cancer Res Ther; 2024 Jan; 20(1):482-484. PubMed ID: 38554371
[TBL] [Abstract] [Full Text] [Related]
16. External validation of a four-tiered grading system for chromophobe renal cell carcinoma.
Liu S; Hou M; Yao Y; Mei J; Sun L; Zhang G
Clin Exp Med; 2024 Mar; 24(1):61. PubMed ID: 38554222
[TBL] [Abstract] [Full Text] [Related]
17. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
[TBL] [Abstract] [Full Text] [Related]
18. High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
Baraban EG; Elias R; Lin MT; Ged Y; Zhu J; Pallavajjala A; Singla N; Lotan TL; Argani P; Eshleman JR; Epstein JI
Mod Pathol; 2024 May; 37(5):100472. PubMed ID: 38492778
[TBL] [Abstract] [Full Text] [Related]
19. The long-term outcomes of local tumor destruction versus partial nephrectomy for cT1a non-clear cell renal cell carcinoma and development of prognostic nomograms.
Qiu J; Deng R; Zhao Z; Tian P; Zhou J
J Cancer Res Clin Oncol; 2024 Mar; 150(3):122. PubMed ID: 38472549
[TBL] [Abstract] [Full Text] [Related]
20. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
[TBL] [Abstract] [Full Text] [Related]
[Next]
